Evidence map›Paper›PMID 41255822›Full record

ArticleFrontiers in neuroscience2025

Neuroimaging and molecular mechanism of action of Cang-ai volatile oil in the treatment of vascular cognitive impairment.

Bojun Chen, Boshen Liang, Wei Li, Lei Wang, Jiaojian Wang, Lei Xiong, Fabao Gao

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bojun Chen *Yunnan University of Chinese Medicine, Kunming, China.
Boshen Liang *Guangzhou University of Chinese Medicine, Guangzhou, China.
Wei LiKunming University of Science and Technology, Kunming, China.
Lei WangDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, China.
Jiaojian WangKunming University of Science and Technology, Kunming, China.
Lei XiongYunnan University of Chinese Medicine, Kunming, China.
Fabao GaoYunnan University of Chinese Medicine, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cangai volatile oil (CAVO), as a traditional Chinese medicinal volatile oil, has been applied for its neuroprotective effects in conditions such as depression. Objective: To investigate whether CAVO can improve brain cognitive function in rats with vascular cognitive impairment using 7T high-field functional magnetic resonance imaging and molecular biology. Method: CAVO treatment was administered in a rat model of vascular dementia induced by bilateral permanent occlusion of the common carotid arteries (2 VO). The water maze was employed for behavioral assessment, while magnetic resonance imaging examined alterations in local homogeneity, low-frequency amplitude, and functional connectivity within the rat brain. Protein expression of inflammatory factors (NLRP3), apoptotic proteins (BAX, Bcl-2), and endoplasmic reticulum stress proteins (CHOP, PERK, GRP78) in the rat hippocampus was analyzed using Western blotting and PCR. Results: CAVO enhances functional connectivity strength in regions including the cingulate cortex-piriform cortex and anterior cingulate cortex-hypothalamus in VCI rats ( Conclusion: This study demonstrates that CAVO therapy reduces inflammatory responses in brain regions of VCI rats, decreases apoptosis and necrosis, protects neurons in affected areas, and simultaneously enhances functional connectivity strength between brain regions in VCI rats, thereby exerting a cognitive-improving effect on VCI.

Indexed as

apoptosisCang-ai volatile oilendoplasmic reticulum stressinflammationneuroimagingvascular cognitive impairment

Identifiers

PMID41255822
PMCPMC12620445

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.